drugset / Trial / NCT04773353
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Women
RandomizedParallel-groupSingle-blindTreatment
Summary
To demonstrate non-inferiority of FE 999049 compared with GONAL-F with respect to ongoing pregnancy rate in women undergoing controlled ovarian stimulation.
Timeline
- Start
- 2021-12-03
- Primary completion
- 2023-12-12
- Completion
- 2023-12-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Follitropin delta | Protein / enzyme biologic | 0.1 ug/kg | Subcutaneous |
| Subject | Follitropin delta | Protein / enzyme biologic | 0.19 ug/kg | Subcutaneous |
| Subject | Follitropin delta | Protein / enzyme biologic | 12 ug | Subcutaneous |
| Subject | Gonal-f | Protein / enzyme biologic | 150 iu | Subcutaneous |